Biller L, Schmidt H, Krause E, Gelhaus C, Handal G, Lotter H, Janssen O, Tannich E, Bruchhaus I.
Comparison of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties.
Proteomics 9: 4107-4120, 2009
Blum KS, Tong Y, Siebert R, Marget M, Humpe H, Neppert J, Flesch BK.
Evidence for gene recombination in FCGR3 gene variants
Vox Sang, 97: 69-67, 2009
Chiplunkar S, Dhar S, Wesch D, Kabelitz D.
γδ T cells in cancer immunotherapy: current status and future prospects
Immunotherapy 4: 663-678, 2009
Deerberg A, Sosna J, Thon L, Belka C, Adam D.
Differential protection by wildtype vs. organelle-specific Bcl-2 suggests a combined requirement of both the ER and mitochondria in ceramide-mediated caspase-independent programmed cell death.
Radiat Oncol 4: 41, 2009
Entschladen F, Lindquist JA, Serfling E, Thiel G, Kieser A, Giehl K, Erhardt C, Feller SM, Ullrich O, Janssen O, Hass R, Friedrich KH.
Signal transduction - receptors mediators and genes.
Sci Signal 2: mr3, 2009
Friedrich KH, Lindquist JA, Entschladen F, Serfling E, Thiel G, Kieser A, Giehl K, Erhardt C, Feller SM, Ullrich O, Janssen O, Hass R.
Signal transduction in the foodsteps of Goethe and Schiller.
Cell Commun Signal 7: 2, 2009
Kabelitz D, Schreiber S.
Autoimmunität - Physiologische Kontrollmechanismen und Wege zur Autoimmunerkrankung
Internist 50: 267-275, 2009
Kabelitz D,
Introductory overview: gd T-cells at the cross-road of innate and adaptive immunity. The Open Immunology Journal 2: 103-105, 2009
Kabelitz D, Wesch D Cellular Diagnostics: Basic Principles, Methods and
Clinical Applications of Flow Cytometry, U Sack, A Tarnok, G Rothe (eds.),
T-Cell Receptor Repertoire Analysis by Flow Cytometry, S Karger Verlag, pp.
200-210, 2009
Klettner AK, Kruse ML, Meyer T, Wesch D, Kabelitz D, Roider J.
Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accululates in RPE cells.
Graefes Arch Clin Exp Ophtalmol, 247:1601-1608, 2009
Krause S, Latendorf T, Schmidt H, Darcan-Nicolaisen Y, Reese G, Petersen A, Janssen O, Becker W-M.
Peanut varieties with reduced Ara h 1 content indicating no reduced allergenicity.
Mol Nutr Food Res, 54:381-7, 2009
Lettau M, Pieper J, Janssen O.
Nck adapter proteins: Functional versatility in T cells.
Cell Commun Signal 7: 1, 2009
Lettau M, Paulsen M, Kabelitz D, Janssen O.
FasL retrograde signalling.
In: Kalthoff H (Ed) Results Probl Cell Differ. 49 - Death Receptors and Cognate Lgands in Cancer. 2009, Springer, pp49-61
Liao W, Fujita KI, Xiao Q, Tchikov V, Yang W, Gunsor M, Garfield S, Goldsmith P, El-Deiry WS, Schutze S, Srinivasula SM.
Response: CARP1 regulates induction of NF-kappaB by TNFalpha.
Curr Biol. 19: R17-R19, 2009
Linkermann A, Gelhaus C, Lettau M, Qian J, Kabelitz D, Janssen O.
Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes
Biochim Biophys Acta - Proteins and Proteomics. 1794: 168-176, 2009
Marischen L, Wesch D, Schröder JM, Wiedow O, Kabelitz D.
Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin.
Scand J Immunol. 70:547-552, 2009
Mirghomizadeh F, Winoto-Morbach S, Orinska Z, Lee KH, Schütze S, Bulfone-Paus S.
Intracellular IL-15 controls mast cell survival.
Exp Cell Res, 315: 3064-3075, 2009
Mirghomizadeh F, Bullwinkel J, Orinska Z, Janssen O, Petersen A, Singh PB, Bulfone-Paus S.
Transcriptional regulation of mouse mast cell protease-2 by IL-15.
J. Biol. Chem. 284: 32635-32641, 2009
Ohnesorge S, Oberg H-H, Peters C, Janssen O, Kabelitz D, Wesch D.
Differential Poly(I:C) responses of human Vg9Vd2 T cells stimulated with pyrophosphates versus aminobisphosphonates.
Open Immunology Journal. 2009, 2:135-142
Paulsen M*, Mathew B*, Lettau M, Kabelitz D, Janssen O.
FasL crosslinking inhibits activation of human peripheral T cells.
Int Immunol, 21: 587-598, 2009
Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg HH, Wesch D, Kabelitz D.
Toll-like receptor expression and function in subsets of human gamma-delta T lymphozytes
J Immunol 70: 245 255, 2009
Schmidt H, Gelhaus C, Latendorf T, Nebendahl M, Petersen A, Krause S, Leippe M, Becker WM, Janssen O.
2D-DIGE analysis of the proteome of extracts from peanut variants reveals striking differences in major allergen contents.
Proteomics 9: 3507-3521, 2009
Schmidt H, Gelhaus C, Lucius R, Nebendahl M, Leippe M, Janssen O:
Enrichment and analysis of secretory lysosomes from lymphocyte populations.
BMC Immunology 10: 41, 2009
Schütze S, Schneider-Brachert W.
Impact of TNF-R1 and CD95 Internalization on Apoptotic and Antiapoptotic Signaling.
In: Kalthoff H (Ed) Results Probl Cell Differ. 49 - Death Receptors and Cognate Lgands in Cancer. 2009, Springer, pp63-85
Shojaei H, Oberg HH, Juricke M, Marischen L, Kunz M, Mundhenke C, Gieseler F, Kabelitz D, Wesch D.
Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by gammadelta T cells.
Cancer Res. 69:8710-8717, 2009
von Bismarck P, Klemm K, García Wistädt CF, Winoto-Morbach S, Schütze S, Krause MF.
Selective NF-kappaB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model.
Pulm Pharmacol Ther. 22: 297-303, 2009
Voss M*, Lettau M*, Janssen O.
Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
BMC Immunology 10: 53, 2009
*equally contributing first authors
Yazdanpanah B., Wiegmann K., Tchikov V., Krut O., Pongratz C., Schramm M., Kleinridders A., Wunderlich T., Kashkar H., Utermöhlen O., Brüning JC., Schütze S., Krönke M.
Riboflavin kinase couples TNF receptor 1 to NADPH oxidase
Nature 460: 1159-1163, 2009
